NCT06638801 Brain Uptrain to Improve Learning and Development
| NCT ID | NCT06638801 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Alabama at Birmingham |
| Condition | Term Infant |
| Study Type | INTERVENTIONAL |
| Enrollment | 188 participants |
| Start Date | 2025-02-18 |
| Primary Completion | 2029-02-18 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 188 participants in total. It began in 2025-02-18 with a primary completion date of 2029-02-18.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to see if an early literacy and developmental program in addition to shared reading can increase developmental test scores at 24 months of age. All caregivers of infants in this study will receive shared reading training. Half of the caregivers will be trained in an additional coach-led caregiver-implemented early literacy and numeracy program. Information related to infant development will be collected from parent surveys, medical records, and questionnaires and assessments.
Eligibility Criteria
Inclusion Criteria: inborn at UAB, delivered at more than 35 weeks' gestation, planned for discharge home after initial hospitalization. \- Exclusion Criteria: a major malformation, a known syndrome, admitted to the NICU, in DHR custody, enrolled in a competing study, and family's primary language is other than English or Spanish. \-
Contact & Investigator
Colm P Travers
PRINCIPAL INVESTIGATOR
University of Alabama at Birmingham
Frequently Asked Questions
Who can join the NCT06638801 clinical trial?
This trial is open to participants of all sexes, aged 1 Day or older, up to 7 Days, studying Term Infant. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06638801 currently recruiting?
Yes, NCT06638801 is actively recruiting participants. Contact the research team at cptravers@uabmc.edu for enrollment information.
Where is the NCT06638801 trial being conducted?
This trial is being conducted at Birmingham, United States.
Who is sponsoring the NCT06638801 clinical trial?
NCT06638801 is sponsored by University of Alabama at Birmingham. The principal investigator is Colm P Travers at University of Alabama at Birmingham. The trial plans to enroll 188 participants.